+

WO2003100036A3 - Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih. - Google Patents

Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih. Download PDF

Info

Publication number
WO2003100036A3
WO2003100036A3 PCT/FR2003/001612 FR0301612W WO03100036A3 WO 2003100036 A3 WO2003100036 A3 WO 2003100036A3 FR 0301612 W FR0301612 W FR 0301612W WO 03100036 A3 WO03100036 A3 WO 03100036A3
Authority
WO
WIPO (PCT)
Prior art keywords
sulpholipids
same
spirulinae
inhibitors
extracted
Prior art date
Application number
PCT/FR2003/001612
Other languages
English (en)
Other versions
WO2003100036A2 (fr
Inventor
Quoc Kiet Pham
Hubert Durand-Chastel
Original Assignee
Quoc Kiet Pham
Hubert Durand-Chastel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quoc Kiet Pham, Hubert Durand-Chastel filed Critical Quoc Kiet Pham
Priority to AU2003255611A priority Critical patent/AU2003255611A1/en
Priority to US10/512,858 priority patent/US20050245463A1/en
Priority to MXPA04011901A priority patent/MXPA04011901A/es
Publication of WO2003100036A2 publication Critical patent/WO2003100036A2/fr
Publication of WO2003100036A3 publication Critical patent/WO2003100036A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P11/00—Preparation of sulfur-containing organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouveaux sulfolipides extraits de spirulines, leur procédé d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs des virus VIH-1 et VIH-2. L'invention concerne également une biomasse de spirulines riche en sulfolipides ayant une activité inhibitrice de la transcriptase inverse de VIH-1 et VIH-2, ainsi que l'utilisation desdits sulfolipides ou d'un extrait de biomasse de spiruline riche en sulfolipides pour la préparation d'un médicament pour le traitement prophylactique ou curatif du SIDA.
PCT/FR2003/001612 2002-05-29 2003-05-28 Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih. WO2003100036A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2003255611A AU2003255611A1 (en) 2002-05-29 2003-05-28 Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase
US10/512,858 US20050245463A1 (en) 2002-05-29 2003-05-28 Novel antiretroviral sulfolipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase
MXPA04011901A MXPA04011901A (es) 2002-05-29 2003-05-28 Sulfolipidos antiretrovirales novedosos extraidos de las espirulinas, metodo para obtenerlos, composiciones que los contienen y uso de los mismos como inhibidores de la transcriptasa inversa del virus vih.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR02/06546 2002-05-29
FR0206546A FR2840318B1 (fr) 2002-05-29 2002-05-29 Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih

Publications (2)

Publication Number Publication Date
WO2003100036A2 WO2003100036A2 (fr) 2003-12-04
WO2003100036A3 true WO2003100036A3 (fr) 2004-05-06

Family

ID=29558799

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/001612 WO2003100036A2 (fr) 2002-05-29 2003-05-28 Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih.

Country Status (6)

Country Link
US (1) US20050245463A1 (fr)
CN (1) CN100404662C (fr)
AU (1) AU2003255611A1 (fr)
FR (1) FR2840318B1 (fr)
MX (1) MXPA04011901A (fr)
WO (1) WO2003100036A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2516C2 (ro) * 2004-04-07 2005-03-31 Валериу РУДИК Remediu medicamentos antiinflamator, antiseptic şi antifungic sub formă de gel
US20070224216A1 (en) * 2004-05-04 2007-09-27 Jane Teas Methods and Compositions Related to Antiviral Therapy Using Algae and Cyanobacteria
MD2671G2 (ro) * 2004-08-10 2005-08-31 Валериу РУДИК Remediu medicamentos antivirotic şi antiherpetic sub formă de gel
CN103209987B (zh) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 取代的核苷酸类似物
EP2794630A4 (fr) 2011-12-22 2015-04-01 Alios Biopharma Inc Analogues de nucléotide phosphorothioate substitués
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
EP2827876A4 (fr) 2012-03-22 2015-10-28 Alios Biopharma Inc Combinaisons pharmaceutiques comprenant un analogue thionucléotidique
AU2015294769B2 (en) * 2014-07-24 2020-07-16 Litevax B.V. Adjuvants
KR20170025977A (ko) * 2015-08-31 2017-03-08 재단법인차세대융합기술연구원 옥시리스 마리나로부터 분리된 신규 화합물
CN107778337B (zh) * 2016-08-26 2020-12-08 国投生物科技投资有限公司 超临界二氧化碳萃取螺旋藻中糖脂的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002521A1 (fr) * 1989-08-15 1991-03-07 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Compositions antivirales contenant des derives de glycerol de sulfoquinovosyle et des analogues de ceux-ci et procedes les utilisant
FR2768744A1 (fr) * 1997-09-19 1999-03-26 Quoc Kiet Pham Procede de culture mixotrophique de spirulines pour la production d'une biomasse riche en acides gras polyinsatures omega 6 et/ou en sulfolipides
EP1172107A1 (fr) * 1999-02-26 2002-01-16 Toyo Suisan Kaisha, Ltd. Medicaments contenant des derives du sulfopyranosylacylglycerol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
SE9601677D0 (sv) * 1996-05-02 1996-05-02 Scotia Lipidteknik Ab New use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002521A1 (fr) * 1989-08-15 1991-03-07 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Compositions antivirales contenant des derives de glycerol de sulfoquinovosyle et des analogues de ceux-ci et procedes les utilisant
FR2768744A1 (fr) * 1997-09-19 1999-03-26 Quoc Kiet Pham Procede de culture mixotrophique de spirulines pour la production d'une biomasse riche en acides gras polyinsatures omega 6 et/ou en sulfolipides
EP1172107A1 (fr) * 1999-02-26 2002-01-16 Toyo Suisan Kaisha, Ltd. Medicaments contenant des derives du sulfopyranosylacylglycerol

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
AYEHUNIE S ET AL: "INHIBITION OF HIV-1 REPLICATION BY AN AQUEOUS EXTRACT OF SPIRULINA PLATENSIS (ARTHROSPIRA PLATENSIS)", JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, LIPPINCOT-RAVEN, XX, vol. 18, no. 1, 1998, pages 7 - 12, XP001055551, ISSN: 1077-9450 *
BLINKOVA L P ET AL: "Biological activity of Spirulina platensis.", ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, no. 2, March 2001 (2001-03-01), pages 114 - 118, XP008012772, ISSN: 0372-9311 *
D.M. GORDON ET AL: "synthesis of a Cyanobacterial sulfolipid: Confirmation of its structure, stereochemistry, and Anti-HIV-1 activity", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 114, 1992, pages 659 - 663, XP002271064 *
DURAND-CHASTEL HUBERT: "Production of Spirulina biomass rich in gamma-linolenic acid and sulfolipids.", BULLETIN DE L'INSTITUT OCEANOGRAPHIQUE (MONACO), no. SPEC. ISSUE 19, 1999, pages 541 - 546, XP008012812, ISSN: 0304-5722 *
GUSTAFSON K R ET AL: "AIDS-ANTIVIRAL SULFOLIPIDS FROM CYANOBACTERIA (BLUE-GREEN ALGAE)", JOURNAL OF THE NATIONAL CANCER INSTITUTE, US DEPT. OF HEALTH, EDICATIONAND WELFARE, PUBLIC HEALTH, US, vol. 81, no. 16, 16 August 1989 (1989-08-16), pages 1254 - 1258, XP001055127, ISSN: 0027-8874 *
HANASHIMA S ET AL: "STRUCTURE-ACTIVITY RELATIONSHIP OF A NOVEL GROUP OF MAMMALIAN DNA POLYMERASE INHIBITORS SYNHTHETIC SULFOQUINOVOSYLACYLGLYCEROLS", JAPANESE JOURNAL OF CANCER RESEARCH, JAPANESE CANCER ASSOCIATION, TOKYO, JP, vol. 91, October 2000 (2000-10-01), pages 1073 - 1083, XP002945479, ISSN: 0910-5050 *
KIET PHAM QUOC ET AL: "Biosynthesis of eukaryotic lipid molecular species by the cyanobacterium Spirulina platensis", BIOCHIMICA AND BIOPHYSICA ACTA, vol. 1168, 1993, pages 94 - 99, XP008012741 *
KIET PHAM QUOC ET AL: "Effect of growth temperature on the biosynthesis of eukaryotic lipid molecular species by the cyanobacterium Spirulina platensis", BIOCHIMICA BIOPHYSICA ACTA, vol. 1346, no. 3, 23 June 1997 (1997-06-23), pages 237 - 246, XP002055201 *
MORIMOTO T ET AL: "STUDIES ON GLYCOLIPIDS. VII. ISOLATION OF TWO NEW SULFOQUINOVOSYL DIACYLGLYCEROLS FROM THE GREEN ALGA CHLORELLA VULGARIS", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN. TOKYO, JP, vol. 41, no. 9, 1993, pages 1545 - 1548, XP002928282, ISSN: 0009-2363 *
S. LOYA ET AL: "The inhibition of the Reverse transcriptase of HIV-1 by the natural Sulfoglycolipids from cyanobacteria: Contribution of different moieties to their high potency", JOURNAL OF NATURAL PRODUCTS, vol. 61, 1998, pages 891 - 895, XP002228775 *
XUE CHANGHU ET AL: "Molecular species composition of glycolipids from Sprirulina platensis.", FOOD CHEMISTRY, vol. 77, no. 1, May 2002 (2002-05-01), May, 2002, pages 9 - 13, XP002228776, ISSN: 0308-8146 *

Also Published As

Publication number Publication date
MXPA04011901A (es) 2005-03-31
CN1656212A (zh) 2005-08-17
FR2840318A1 (fr) 2003-12-05
WO2003100036A2 (fr) 2003-12-04
US20050245463A1 (en) 2005-11-03
CN100404662C (zh) 2008-07-23
AU2003255611A1 (en) 2003-12-12
FR2840318B1 (fr) 2004-12-03

Similar Documents

Publication Publication Date Title
WO2005115398A3 (fr) Inhibiteurs d'integrase de vih
WO2004096818A3 (fr) Procede et compositions pour l'identification de composes therapeutiques anti-vih
MXPA03009380A (es) Derivados de pirazol.
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
NO20010743L (no) Antivirale indoloksoacetyl-piperazin-derivater
WO2007013047A3 (fr) Compositions pharmaceutiques anti-retrovirales dispersibles dans l'eau
WO2002100845A8 (fr) Inhibiteurs de protease du hiv et compositions contenant ceux-ci, leurs applications pharmaceutiques, et matieres utiles a la synthese de ces inhibiteurs
TW200745100A (en) Use of a sulfonamide compound for improving the pharmacokinetics of a drug
EP0887427A3 (fr) Amplification et détection du HIV-1 et/or HIV-2
MX9706913A (es) Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
WO2006122003A3 (fr) Diaryl-purine, -azapurines et -deazapurines inhibiteurs non nucleosidiques de la transcriptase inverse utilises dans le traitement du vih
MX9706947A (es) Inhibidores de proteasa retroviral de sulfonilalcanoilamino-hidroxietilamino-sulfonamida y uso de los mismos.
WO2003100036A3 (fr) Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih.
GB0113524D0 (en) Pyrazole derivatives
WO2004002410A3 (fr) 2,4-disubstitutee-pyridine n-oxydes utiles comme inhibiteurs de la transcriptase inverse du vih
MY126450A (en) Crystalline efavirenz
WO2007002172A3 (fr) Inhibiteurs de la protease du vih-1
ZA991029B (en) Composition and methods for treatment of hiv infections.
DE60213874D1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
WO2004029201A3 (fr) Inhibiteurs de fusion contre l'infection au vih derives de peptides
MX9700414A (es) Agentes antivirales de difluoroestatona.
WO2004103278A3 (fr) Acyle sulfonamides servant d'inhibiteurs d'integrase du vih
MXPA04004061A (es) Derivados de quinolina y piridina antiretrovirales.
NO20081230L (no) Inhibitorer av enzymet HIV integrase
TW200505872A (en) Hepatitis C virus inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10512858

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/011901

Country of ref document: MX

Ref document number: 20038123150

Country of ref document: CN

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载